In this interview with Insights Success, Jeff Aronin discusses Paragon Biosciences’ portfolio company Evozyne’s role in technical advancements in genetics and supercomputing in the midst of some of society’s most pressing challenges. Read more of… Read more
Chad Mirkin, the most cited chemist in the world in 2010 and a world-renowned scientific innovator, discusses his entrepreneurial approach with Paragon Biosciences CEO Jeff Aronin.
Jeff recently spoke with Pulitzer-prize winning journalist Kathleen Gallagher on her podcast “How Did You Do That?”, discussing his expansive career in life sciences and why he is committed to solving some of the world’s… Read more
The latest edition of Insights Success magazine highlights the efforts of Jeff Aronin, Paragon Biosciences chairman and CEO, to build innovative life science companies that are developing solutions for both human disease and societal challenges…. Read more
Jeff Aronin, Chairman and CEO of Paragon Biosciences, has spent more than two decades in one of the most challenging areas of the biosciences sector. He and his teams have worked to find treatments for… Read more
Paragon Biosciences is a life science innovator that invests in, builds, and advises bioscience companies. Their mission is to serve patients living with severe medical conditions which do not yet have adequate treatments. Watch the… Read more
As Chairman and CEO of Paragon Biosciences, Jeffrey Aronin has invested in and launched several successful portfolio companies, including: Harmony Biosciences, Castle Creek Pharma, Emalex Biosciences, and Skyline Biosciences. Previously, Mr. Aronin served as President and CEO of… Read more